Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-06
Biography and Research Information
OverviewAI-generated summary
Piyanan Chuesiang's research focuses on the development and characterization of various delivery systems for bioactive compounds, with a particular emphasis on enhancing stability and bioavailability. Chuesiang has investigated nanostructured lipid carriers, oleogels, and Pickering emulsions stabilized by complex biopolymers like cellulose nanocrystals and whey protein isolate for delivering compounds such as curcumin.
Further work includes exploring the effects of cold plasma treatment on chitosan films to improve their properties and developing green active coatings from chitosan incorporated with cinnamon oil nanoemulsion for food preservation. Chuesiang has also studied microfluidized essential oil nanoemulsions for their antimicrobial activity and the use of micellar delivery systems to enhance curcumin's stability and photoinactivation capacity. The researcher's work has resulted in 30 publications with an h-index of 16 and 884 total citations.
Metrics
- h-index: 16
- Publications: 30
- Citations: 884
Selected Publications
-
CD5L promotes efferocytosis and resolution of retinal ischemic injury (2026)
-
Myeloid HDAC3 deletion protects against traumatic optic injury (2026)
-
HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis (2025)
Collaboration Network
Top Collaborators
Abdelrahman Y. Fouda
Cairo University
3 shared publications
In database
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- Myeloid HDAC3 deletion protects against traumatic optic injury
- CD5L promotes efferocytosis and resolution of retinal ischemic injury
Carol Morris
University of Arkansas for Medical Sciences
2 shared publications
In database
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- Myeloid HDAC3 deletion protects against traumatic optic injury
Melissa Wild
University of Arkansas for Medical Sciences
2 shared publications
In database
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- CD5L promotes efferocytosis and resolution of retinal ischemic injury
A. J. Cunningham
University of Arkansas for Medical Sciences
2 shared publications
In database
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- Myeloid HDAC3 deletion protects against traumatic optic injury
Nancy J. Rusch
University of Arkansas for Medical Sciences
2 shared publications
In database
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- CD5L promotes efferocytosis and resolution of retinal ischemic injury
Esraa Shosha
Cairo University
2 shared publications
In database
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- CD5L promotes efferocytosis and resolution of retinal ischemic injury
Christian D. Mitchell
University of Arkansas for Medical Sciences
1 shared publication
In database
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
Aya A Mohammed
University of Arkansas for Medical Sciences
1 shared publication
In database
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
Bolni Marius Nagalo
Winthrop Rockefeller Foundation
1 shared publication
In database
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
Rami Ahmad Shahror
University of Arkansas for Medical Sciences
1 shared publication
In database
- Myeloid HDAC3 deletion protects against traumatic optic injury
Rami A. Shahror
University of Arkansas for Medical Sciences
1 shared publication
In database
- CD5L promotes efferocytosis and resolution of retinal ischemic injury
Bushra Zaman
University of Arkansas for Medical Sciences
1 shared publication
In database
- CD5L promotes efferocytosis and resolution of retinal ischemic injury
Yuet‐Kin Leung
University of Arkansas for Medical Sciences
1 shared publication
In database
- CD5L promotes efferocytosis and resolution of retinal ischemic injury
Shengyu Mu
University of Arkansas for Medical Sciences
1 shared publication
In database
- CD5L promotes efferocytosis and resolution of retinal ischemic injury
Similar Researchers
Based on overlapping research topics
Sankar Devarajan
University of Arkansas at Pine Bluff
Nanoparticles: synthesis and applications
Drug Delivery Systems
Food composition and properties
Ali Ubeyitogullari
University of Arkansas at Fayetteville
Nanoparticles: synthesis and applications
Drug Delivery Systems
Food composition and properties
Carlie M. Clem
University of Arkansas at Fayetteville
Nanoparticles: synthesis and applications
Drug Delivery Systems
Materials Science Research
Matthias D.R. Lenie
University of Arkansas at Fayetteville
Drug Delivery Systems
Food composition and properties
Phytochemicals and Antioxidant Activities
Safoura Ahmadzadeh
University of Arkansas at Fayetteville
Nanoparticles: synthesis and applications
Food composition and properties
Materials Science Research
Gurshagan Kandhola
University of Arkansas at Fayetteville
Nanoparticles: synthesis and applications
Drug Delivery Systems
Food composition and properties